Publisher Correction: MiR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells.

ABSTRACT

Correction to Eur Rev Med Pharmacol Sci 2015; 19 (17) 3208-3217. PMID 26400524-published online on September 14, 2015. After publication, a reader brought to our attention a mistake in Figure 4. The journal found that Figure 3 was mistakenly inserted twice in the galley proof, resulting in the publication of the same figure for Figures 3 and 4. The publisher is, therefore, substituting Figure 4 with the correct figure provided at the time of submission as follows There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause. https//www.europeanreview.org/article/9429.